Related Experiment Video
Updated: May 22, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Congenital acute megakaryocytic leukemia
N B Mathur1, Neha Joshi, T Singh
1Department of Pediatrics, Maulana Azad Medical College, Delhi, India.
Summary
Congenital leukemia (CL) is a rare and aggressive newborn disorder, often of myeloid origin. Acute myeloid leukemia-M7 (AML-M7) is a rare subtype presenting with diverse symptoms in children.
Area of Science:
- Hematology
- Pediatric Oncology
- Neonatology
Background:
- Congenital leukemia (CL) is an exceptionally rare condition affecting newborns.
- A significant proportion of CL cases are of myeloid origin, specifically M4 or M5 morphology.
- CL is characterized by a more aggressive clinical course compared to pediatric leukemia.
Observation:
- Acute myeloid leukemia subtype M7 (AML-M7), also known as acute megakaryocytic leukemia, is a rare form of AML.
- The incidence of AML-M7 is approximately 0.5 per million individuals annually.
- Median age of presentation for AML-M7 is 6 years, with children exhibiting varied symptoms.
Findings:
- Newborns with congenital leukemia face a more aggressive disease progression.
- Acute myeloid leukemia-M7 (AML-M7) is a rare subtype with a low incidence rate.
- Symptoms of AML-M7 in children range from mild issues like fever and bruising to severe, life-threatening conditions.
Implications:
- Understanding the aggressive nature of CL is crucial for timely diagnosis and intervention in newborns.
- Further research into AML-M7 is needed to improve outcomes for affected children.
- Early recognition of diverse symptoms in children with AML-M7 can facilitate prompt medical care.
More Related Videos
Related Concept Videos
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:21Lineage Commitment
Commitment is the process whereby stem cells:
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...